期刊文献+

长效干扰素研究进展 被引量:12

The Advance in Long Effect Interferon Reserch
原文传递
导出
摘要 干扰素是一类多功能细胞因子,是由哺乳动物细胞受到适宜刺激产生的一种微量的、具高度生物学活性的蛋白质,具有抵抗病毒感染、抑制肿瘤生长和调节机体免疫功能的作用。干扰素α血浆半衰期短而丙型和乙型肝炎治疗周期长,影响了患者的依从性。目前延长蛋白药物半衰期的方法主要有化学修饰、蛋白融合、定点突变技术联合和改造药物制剂释放系统,随着又一新型长效干扰素ZALBIN即将上市,长效干扰素再次成为医药行业的聚焦点。现针对干扰素α长效制剂中的最新研究进展进行综述。 Interferons are a class of cytokines that play key roles in the regulation of cell growth and differentiation via activation of a cascade of intracellular pathways and represented the functions of antiviral,immunomodulatory,and antiproliferative effects,which are synthesized and secreted by somatic cells of all mammalian species.Interferon alpha(IFN-α)are used in clinic to treat a variety of viral diseases and cancers.Howerver,the short circulating half-life of IFN-α necessitates frequent administration to patients which limits the broader usage.The methods of prolonging the half-life of protein drug in common use are chemical modification,albumin fusion technology,analog construction and combination with drug delivery system.Herein the method of prolonging the half-life of IFN-α in the above-mentioned of the latest research methods were reviewed.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第5期122-127,共6页 China Biotechnology
关键词 干扰素Α 半衰期 定点突变 PEG化 白蛋白融合 IFN-α Half-life Site-directed mutagenesis PEGylation Albumin fusion
  • 相关文献

参考文献4

二级参考文献71

  • 1牛晓霞,刘金毅,杨轶,吴晓东.集成干扰素突变体Ⅱ的分子构建、表达及提纯[J].中国生物工程杂志,2006,26(12):1-5. 被引量:4
  • 2Férir G, Kaptein S, Neyts J, De Clercq E. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future. Rev Med Virol 2008; 18: 19-34. 被引量:1
  • 3Yu ML, Huang CF, Dai CY, Huang JF, Chuang WL. Long-term effects of interferon-based therapy for chronic hepatitis C. Oncology 2007; 72: 16-23. 被引量:1
  • 4Uzé G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type Ⅰ interferon family. Curr Top Microbiol Immunol 2007; 316: 71-95. 被引量:1
  • 5Pogorzelska J, Flisiak R. Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine. Przegl Epidemiol 2007; 61: 433-7. 被引量:1
  • 6Zhou S, Deng X, He S, Li X, Jia W, Wei D, et al. Study on biodegradable microspheres containing recombinant interferon-alpha-2a. J Pharm Pharmacol 2002; 54: 1287-92. 被引量:1
  • 7Sánchez A, Tobío M, González L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003; 18: 221-9. 被引量:1
  • 8Krasowska D, Chodorowska G, Bartosinska J, Warminska J, Jermak A, Kur A, et al. Serum levels of neopterin in patients with lichen planus. Ann Univ Mariae Curie Sklodowska 2004; 59: 346-50. 被引量:1
  • 9Xu AL, Yang F, Gao JP, Zhao YM, Wang L, Dong ML, inventors; Sun Yat-Sen University, Guangzhou. A method for preparation of Interferon-loaded biodegradable PLGA microspheres. China patent 1660412A. 2005 Aug 31. 被引量:1
  • 10Reich G. Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables. Eur J Pharm Biopharm 1998; 45: 165-71 被引量:1

共引文献16

同被引文献100

引证文献12

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部